Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson & Johnson (Pty) Ltd

http://www.jnjsouthafrica.co.za

Latest From Johnson & Johnson (Pty) Ltd

FTC Launches ‘Colonoscopy’ Into PBM Practices, Including Focus On Consumer Costs, Access

Study will examine how the six largest pharmacy benefit managers in the US handle 10 disease categories. Federal Trade Commissioners unanimously support inquiry after its scope was broadened from an earlier version that drew objections from Republicans.

Pricing Debate Reimbursement

FTC To Investigate PBM Practices, Including Focus On Consumer Costs, Access

Federal Trade Commission study of the six largest pharmacy benefit managers in the US wins the unanimous support of commissioners after its scope was broadened from an earlier version.

Pricing Debate Policy

XACT ACE Robotics System Receives Expanded FDA Clearance For Ablation Procedures

Medtech Insight spoke with XACT Robotics’ executive chairman Harel Gadot about plans for the FDA-cleared ACE robotic system and its market opportunities.

Robotic Surgery FDA

J&J Medtech Appoints Kurt Van den Bosch As CFO

Kurt Van den Bosch has been named CFO of J&J Medtech where he will report directly to Joe Wolk, J&J’s CFO. 

Executive Changes Financing
See All

Company Information

UsernamePublicRestriction

Register